G01N 33/6896
Neurological disorders
Official title: {Neurological disorders, e.g. Alzheimer's disease}
G01N33/6896 (Neurological disorders) appears on 2,306 US grants and 4,915 published applications in this corpus.
Search patents in G01N- Granted patents
- 2,306
- Published applications
- 4,915
- Assignees
- 1,889
- Inventors
- 8,389
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 5 | 0 |
| 1990 | 3 | 0 |
| 1991 | 3 | 0 |
| 1992 | 5 | 0 |
| 1993 | 14 | 0 |
| 1994 | 5 | 0 |
| 1995 | 13 | 0 |
| 1996 | 17 | 0 |
| 1997 | 23 | 0 |
| 1998 | 42 | 0 |
| 1999 | 35 | 0 |
| 2000 | 38 | 0 |
| 2001 | 50 | 16 |
| 2002 | 46 | 114 |
| 2003 | 33 | 157 |
| 2004 | 35 | 172 |
| 2005 | 33 | 198 |
| 2006 | 67 | 201 |
| 2007 | 60 | 168 |
| 2008 | 61 | 146 |
| 2009 | 58 | 190 |
| 2010 | 89 | 178 |
| 2011 | 73 | 173 |
| 2012 | 73 | 155 |
| 2013 | 83 | 201 |
| 2014 | 91 | 229 |
| 2015 | 80 | 181 |
| 2016 | 98 | 206 |
| 2017 | 130 | 212 |
| 2018 | 111 | 209 |
| 2019 | 124 | 216 |
| 2020 | 124 | 215 |
| 2021 | 115 | 253 |
| 2022 | 107 | 252 |
| 2023 | 82 | 233 |
| 2024 | 89 | 231 |
| 2025 | 107 | 233 |
| 2026 | 81 | 176 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- ß-amyloid cyclic ribonucleic acid, polypeptide, and application thereof6 Oct 2026US 12,753,215 B2
- Methods for identifying pre-disposition to cognitive decline and agents for reducing or preventing cognitive decline, or improving cognitive ability29 Sep 2026US 12,746,255 B2Societe des Produits Nestle S. A.
- Tau-binding antibodies29 Sep 2026US 12,747,288 B2Ucb Biopharma Srl
- Methods for detecting phosphorylated alpha-synuclein22 Sep 2026US 12,742,789 B2Prothena Biosciences Limited
- FUS/TLS-based compounds and methods for diagnosis, treatment and prevention of amyotrophic lateral sclerosis and related motor neuron diseases15 Sep 2026US 12,735,745 B2The General Hospital Corporation
- Electrochemical biosensors, systems, and methods of use8 Oct 2026US 2026/0309671 A1
- Tau assay8 Oct 2026US 2026/0309720 A1
- Early detection and monitoring of neurodegenerative diseases using a multidisease diagnostic platform8 Oct 2026US 2026/0309723 A1Durin Life Sciences, Inc.
- Methods and compositions for diagnosing brain injury or neurodegeneration8 Oct 2026US 2026/0309724 A1Brainbox Solutions, Inc.
- A nasal fluid sample comprising abeta, ptau and/or ttau8 Oct 2026US 2026/0309725 A1Noselab GmbH
Most cited
By later US patents
- Technique for extracorporeal treatment of blood460US 5,910,252 ACobe Laboratories, Inc. · 1999
- Polypeptide marker for Alzheimer's disease and its use for diagnosis318US 4,666,829 AUniversity of California · 1987
- Methods for the detection of soluble .beta.-amyloid peptide244US 5,593,846 AAthena Neurosciences, Inc. · 1997
- Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments210US 5,668,117 A1997
- Automatic priming technique208US 5,776,345 ACobe Laboratories, Inc. · 1998